The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Galapagos reported promising results from ATALANTA-1 study show 100% ORR/CR for relapsed Mantle Cell Lymphoma. Click for GLPG ...

Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma with a poor patient ... which revealed that MCL patients who progressed or pre-progressed on acalabrutinib showed a higher ...

after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma. The EMA’s human drugs advisory committee recommended approval of KTE-X19 (autologous anti-CD19-transduced CD3+ cells ...

Mantle cell lymphoma is a unique entity of CD5 +, CD23 − B-cell lymphoma characterized by dysregulation of cyclin D1 by the translocation t(11;14). Despite its dependence on cyclin D1 ...

Blood was tested for the presence of any remaining cancer cells using the clonoSEQ ... of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts ...

Roche has secured approval from the EC for Columvi plus GemOx combo to treat adults with R/R diffuse large B-cell lymphoma ...

Apr. 4, 2025 — A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated ...

1 Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas, USA 2 Department of Pathology, University of Texas Health Science Center, Houston, Texas, USA Mantle cell ...